I have been following some Chinese crypto projects that are really moving from the paper to concrete business. It's not just empty promises, you know?



I started paying more attention to NEO because the story is interesting – they call it the "Chinese Ethereum," but it has its own characteristics. Government support is real, and the two-token model (NEO for governance and GAS for transaction fees) works well in practice.

What really catches my eye is VeChain. Legitimate partnerships with Walmart, BMW, PwC are no joke. The team focuses on supply chain tracking and anti-counterfeiting, which is a real problem in the market. They are also heavily investing in green technologies, which makes sense with global ESG trends.

Conflux is another one worth watching – 3,000 transactions per second is serious speed. The key difference is that it’s the only regulated public blockchain in China, which changes the game quite a bit. Integration with traditional businesses is actually happening, not just theory.

Ontology is more focused on data protection and decentralized identification. Applications in medicine and finance are areas that really need this technology. Compatibility with Ethereum and Polkadot also greatly expands its potential.

What makes me seriously consider these Chinese cryptos is that they’ve come out of a period of heavy regulation and are now returning strongly. This isn’t speculative growth – real business is being built. Of course, diversification remains essential. But projects with real utility and institutional support deserve space in the portfolio.

It’s worth keeping an eye on how these tokens evolve from here.
NEO1,99%
VET2,46%
CFX-1,48%
ONT36,24%
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin